Fred Alger Management’s Aerie Pharmaceuticals AERI Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2022
Q4 | – | Sell |
-598,325
| Closed | -$9.05M | – | 583 |
|
|
2022
Q3 | $9.05M | Sell |
598,325
-461,240
| -44% | -$5.36M | 0.05% | 213 |
|
|
2022
Q2 | $7.95M | Buy |
1,059,565
+549,357
| +108% | +$3.87M | 0.04% | 226 |
|
|
2022
Q1 | $4.64M | Sell |
510,208
-15,214
| -3% | -$117K | 0.01% | 279 |
|
|
2021
Q4 | $3.69M | Sell |
525,422
-558,766
| -52% | -$5.85M | 0.01% | 322 |
|
|
2021
Q3 | $12.4M | Buy |
1,084,188
+17,566
| +2% | +$257K | 0.03% | 226 |
|
|
2021
Q2 | $17.1M | Buy |
1,066,622
+83,257
| +8% | +$1.43M | 0.04% | 215 |
|
|
2021
Q1 | $17.6M | Buy |
983,365
+44,438
| +5% | +$768K | 0.05% | 212 |
|
|
2020
Q4 | $12.7M | Buy |
938,927
+16,882
| +2% | +$204K | 0.03% | 222 |
|
|
2020
Q3 | $10.9M | Sell |
922,045
-794,668
| -46% | -$9.68M | 0.03% | 198 |
|
|
2020
Q2 | $25.3M | Buy |
1,716,713
+319,731
| +23% | +$4.73M | 0.08% | 150 |
|
|
2020
Q1 | $18.9M | Buy |
1,396,982
+326,190
| +30% | +$6.19M | 0.08% | 153 |
|
|
2019
Q4 | $25.9M | Buy |
1,070,792
+579,086
| +118% | +$12M | 0.1% | 160 |
|
|
2019
Q3 | $9.45M | Buy |
491,706
+95,389
| +24% | +$2.19M | 0.04% | 187 |
|
|
2019
Q2 | $11.7M | Buy |
396,317
+120,628
| +44% | +$4.65M | 0.05% | 178 |
|
|
2019
Q1 | $13.1M | Buy |
275,689
+127,664
| +86% | +$5.62M | 0.05% | 178 |
|
|
2018
Q4 | $5.34M | Sell |
148,025
-20,446
| -12% | -$959K | 0.02% | 200 |
|
|
2018
Q3 | $10.4M | Sell |
168,471
-15,060
| -8% | -$968K | 0.04% | 181 |
|
|
2018
Q2 | $12.4M | Sell |
183,531
-141,625
| -44% | -$7.92M | 0.05% | 175 |
|
|
2018
Q1 | $17.6M | Sell |
325,156
-14,787
| -4% | -$827K | 0.08% | 154 |
|
|
2017
Q4 | $20.3M | Sell |
339,943
-12,363
| -4% | -$750K | 0.09% | 141 |
|
|
2017
Q3 | $17.1M | Sell |
352,306
-4,908
| -1% | -$268K | 0.08% | 147 |
|
|
2017
Q2 | $18.8M | Sell |
357,214
-10,443
| -3% | -$486K | 0.09% | 140 |
|
|
2017
Q1 | $16.7M | Buy |
367,657
+118,594
| +48% | +$5.29M | 0.08% | 143 |
|
|
2016
Q4 | $9.43M | Buy |
249,063
+66,649
| +37% | +$2.52M | 0.05% | 150 |
|
|
2016
Q3 | $6.88M | Buy |
182,414
+102,014
| +127% | +$2.25M | 0.04% | 190 |
|
|
2016
Q2 | $1.42M | Buy |
+80,400
| New | +$1.3M | 0.01% | 296 |
|
|
2015
Q4 | – | Sell |
-150,894
| Closed | -$2.68M | – | 603 |
|
|
2015
Q3 | $2.68M | Sell |
150,894
-44,141
| -23% | -$799K | 0.01% | 326 |
|
|
2015
Q2 | $3.44M | Sell |
195,035
-237,654
| -55% | -$4.36M | 0.02% | 343 |
|
|
2015
Q1 | $13.6M | Buy |
432,689
+321,141
| +288% | +$9.31M | 0.06% | 232 |
|
|
2014
Q4 | $3.26M | Buy |
+111,548
| New | +$2.83M | 0.02% | 363 |
|
Fred Alger Management's AERI Position: Q4 2022 in Review
Fred Alger Management sold out of Aerie Pharmaceuticals (AERI) in Q4 2022, closing a stake of 598,325 shares — an estimated $9.05M sold.
Fred Alger Management first reported a position in AERI in Q4 2014 and held it in 30 quarters. The position peaked at $25.9M in Q4 2019. 0 funds tracked by Wall St. Rank hold AERI as of Q4 2022.
- Fred Alger Management reported no remaining Aerie Pharmaceuticals position as of Q4 2022 after selling out during the quarter.
- Fred Alger Management sold 598,325 Aerie Pharmaceuticals shares in Q4 2022, an estimated $9.05M.
- Fred Alger Management first reported a position in Aerie Pharmaceuticals in Q4 2014 and held it in 30 quarters.
- Fred Alger Management's Aerie Pharmaceuticals position peaked at $25.9M in Q4 2019.
- 0 funds tracked by Wall St. Rank held Aerie Pharmaceuticals as of Q4 2022.
Based on Fred Alger Management's 13F filing for Q4 2022, filed 14 Feb 2023.